Literature DB >> 8131752

In vivo assembly of active maltose binding protein from independently exported protein fragments.

J M Betton1, M Hofnung.   

Abstract

The maltose binding protein (MBP or MalE) of Escherichia coli is the periplasmic component of the transport system for malto-oligosaccharides. It is synthesized in the cytoplasm with an N-terminal signal peptide that is cleaved upon export. We examined whether active MBP could assemble into an active protein in bacteria, from N- and COOH-terminal complementary protein fragments encoded by distinct, engineered segments of its structural gene. We found export and functional periplasmic assembly of MBP fragments, despite the complex polypeptide chain topology of this protein, if two conditions were satisfied. First, each of the two fragments must carry a signal peptide. Second, the boundaries between the two fragments must correspond to a permissive site within the protein. Functional assembly of active MBP occurred in five cases where these conditions were met: sites after residues 133, 161, 206, 285 and 303; but not in three other cases where the break junction corresponded to a non-permissive site: after residues 31, 120 and 339. Thus, permissive sites which were initially characterized because they could accept extensive genetic insertion/deletion modifications without loss of most biological properties provide a means of defining complementing protein fragments. This observation opens a way to study genetically the relationships between protein export and folding into the periplasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8131752      PMCID: PMC394932          DOI: 10.1002/j.1460-2075.1994.tb06372.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

Review 1.  Protein folding in vitro and in the cellular environment.

Authors:  J M Yon; J M Betton
Journal:  Biol Cell       Date:  1991       Impact factor: 4.458

2.  Escherichia coli mutants accumulating the precursor of a secreted protein in the cytoplasm.

Authors:  P Bassford; J Beckwith
Journal:  Nature       Date:  1979-02-15       Impact factor: 49.962

3.  Affinity chromatographic isolation of the periplasmic maltose binding protein of Escherichia coli.

Authors:  T Ferenci; U Klotz
Journal:  FEBS Lett       Date:  1978-10-15       Impact factor: 4.124

4.  Nucleation, rapid folding, and globular intrachain regions in proteins.

Authors:  D B Wetlaufer
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  The complete general secretory pathway in gram-negative bacteria.

Authors:  A P Pugsley
Journal:  Microbiol Rev       Date:  1993-03

7.  A direct spectrophotometric assay and determination of Michaelis constants for the beta-lactamase reaction.

Authors:  A Samuni
Journal:  Anal Biochem       Date:  1975-01       Impact factor: 3.365

Review 8.  Folding of protein fragments.

Authors:  D B Wetlaufer
Journal:  Adv Protein Chem       Date:  1981

9.  Role of the mature protein sequence of maltose-binding protein in its secretion across the E. coli cytoplasmic membrane.

Authors:  K Ito; J R Beckwith
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

10.  Active transport of maltose in Escherichia coli K12. Role of the periplasmic maltose-binding protein and evidence for a substrate recognition site in the cytoplasmic membrane.

Authors:  H A Shuman
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

View more
  11 in total

1.  Kinetics and reaction coordinates of the reassembly of protein fragments via forward flux sampling.

Authors:  Ernesto E Borrero; Lydia M Contreras Martínez; Matthew P DeLisa; Fernando A Escobedo
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

2.  In silico protein fragmentation reveals the importance of critical nuclei on domain reassembly.

Authors:  Lydia M Contreras Martínez; Ernesto E Borrero Quintana; Fernando A Escobedo; Matthew P DeLisa
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

3.  Tertiary structure-dependence of misfolding substitutions in loops of the maltose-binding protein.

Authors:  S Raffy; N Sassoon; M Hofnung; J M Betton
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

4.  Topology of the membrane protein LamB by epitope tagging and a comparison with the X-ray model.

Authors:  S M Newton; P E Klebba; V Michel; M Hofnung; A Charbit
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

5.  The interplay between effector binding and allostery in an engineered protein switch.

Authors:  Jay H Choi; Tina Xiong; Marc Ostermeier
Journal:  Protein Sci       Date:  2016-06-24       Impact factor: 6.725

6.  Ligand binding and allostery can emerge simultaneously.

Authors:  Jing Liang; Jin Ryoun Kim; Jason T Boock; Thomas J Mansell; Marc Ostermeier
Journal:  Protein Sci       Date:  2007-03-30       Impact factor: 6.725

7.  In vivo membrane assembly of split variants of the E.coli outer membrane protein OmpA.

Authors:  R Koebnik
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

8.  Split invertase polypeptides form functional complexes in the yeast periplasm in vivo.

Authors:  O Schonberger; C Knox; E Bibi; O Pines
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.

Authors:  Richard A Heins; Jay H Choi; Takayuki Sohka; Marc Ostermeier
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

10.  Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.

Authors:  K W Chan; L Csanády; D Seto-Young; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.